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Beverly S. Emanuel4,5, Elaine H. Zackai4,5,6, Donna M. McDonald-McGinn4,5 and Robert T. Schultz2,6Erratum
After publication of the research article [1], the authors
noticed a minor error in panel d of Fig. 3. The authors
would like to draw the reader’s attention towards the
corrected Fig. 3 below. The corrected panel d reflects a
very minor change which does not change the overall
conclusion of the study.
Figure 3: This figure shows the corrected Fig. 3 of the
original article.
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Fig. 3 Questionnaire results for participants with 22q11.2DupS, 22q11.2DupS and comorbid ASD, idiopathic ASD, and typical development.
Individuals with idiopathic ASD (gray), 22q11.2DS (red), and TDC (green) were compared to individuals with 22q11.2DupS (dashed line) on four
parent-report questionnaires about behavioral symptoms. Error bars represent one standard error. The 22q11.2DupS group was further divided
into individuals who have received a gold standard diagnosis of ASD (DupASD; light blue) and those who did not (DupNoASD; dark blue). On all
measures, individuals with 22q11.2DupS showed scores similar to individuals with 22q11.2DS. However, when the 22q11.2DupS group was
divided into subgroups, individuals in the DupASD subgroup showed scores similar to individuals with idiopathic ASD, whereas individuals in the
DupNoASD subgroup showed mean scores in the average ranges, demonstrating less impairment than individuals with 22q11.2DS. Measures: a
SRS and b CASI-4R: Scores reported in T-scores with mean 50 and SD 10. Scores below 60 considered in normal range. c SCQ: Raw scores
reported. Scores above 15 are strongly suggestive of ASD. d Vineland-II: Scores reported in standard scores with mean 100 and SD 15. Scores
above 90 considered in the average range. Abbreviations: ASD, autism spectrum disorder; CASI-4R, Child and Adolescent Symptom Inventory-4R;
SCQ, Social Communication Questionnaire; SRS, Social Responsiveness Scale; TDC, typically developing children; Vineland-II, Vineland Adaptive
Behavior Scales-II
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